SC 13G
ENDRA LIFE SCIENCES INC.
- Company
- ENDRA Life Sciences Inc.
- Filed
- November 7, 2018
- Accession Number
- 0000905608-18-000011
A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →